Collegeville, PA, United States of America

Sangeeta Raje

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Solvay Pharmaceuticals, B.v.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sangeeta Raje. Retrieved from https://idiyas.com/inventor/sangeeta-raje

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sangeeta Raje: Innovator in Pharmaceutical Dosage Forms

Introduction

Sangeeta Raje is a notable inventor based in Collegeville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel dosage forms. Her work focuses on improving treatment methods for various diseases and disorders.

Latest Patents

Sangeeta Raje holds 1 patent for her invention titled "Bifeprunox mesylate maintenance dose compositions and methods for using the same." This patent provides innovative pharmaceutical dosage forms, including maintenance treatment doses, and outlines methods for their preparation and application in treating and preventing diseases.

Career Highlights

Sangeeta Raje is currently employed at Solvay Pharmaceuticals B.V., where she continues to advance her research and development efforts. Her expertise in pharmaceutical sciences has positioned her as a valuable asset in her field.

Collaborations

Some of her coworkers include Irene Eijgendaal and Gerrit Klein, with whom she collaborates on various projects within the pharmaceutical industry.

Conclusion

Sangeeta Raje's contributions to pharmaceutical innovations highlight her dedication to improving healthcare through her inventive work. Her patent on Bifeprunox mesylate demonstrates her commitment to developing effective treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…